For instance, reduced CYP46A1 activity has been linked to amyloid-beta accumulation and cognitive decline in AD, while altered CYP2D6 expression in the basal ganglia correlates with increased susceptibility to PD. Here, CYP46A1 is linked to Alzheimer disease.